Clinical Trial

Scleroderma Registry & Repository at the Hospital for Special Surgery

Recruiting
View on ClinicalTrials.gov →
Summary
The overall objective of the Scleroderma Registry is to support and promote the basic science and clinical research of this complex rheumatic disease at the Hospital for Special Surgery (HSS). The registry facilitates our understanding of the clinical features, pathobiology, genetics of Scleroderma. This will ultimately lead to a potential treatment for this currently untreatable condition.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2012-08-01; most recent amendment 2025-11-19.
Trial Details
NCT Number NCT01656447
Lead Sponsor Hospital for Special Surgery, New York
Conditions Scleroderma
Enrollment 300 participants
Start Date 2006-08
Primary Completion 2030-01 (estimated)
Study Completion 2030-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-26